<DOC>
	<DOC>NCT00345592</DOC>
	<brief_summary>Demonstrate the efficacy of the device-based managed therapy to treat atrial tachycardia and fibrillation (AT/AF) in patients with CHF indication for implant of a CRT defibrillator and to demonstrate the advantage of automatic electrical therapy of atrial arrhythmias compared to an in-hospital approach for treatment of symptomatic AT/AF.</brief_summary>
	<brief_title>TReatment of Atrial Fibrillation With Dual dEfibrillator in Heart Failure Patients</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>chronic symptomatic HF despite stable, optimal drug therapy indication for a cardiac resynchronisation device with defibrillator backup according to current guidelines patients implanted with cardiac resynchronization device with dual (atrial and ventricular) defibrillation capabilities Chronic atrial fibrillation Valvular disease patients who underwent or are planned for ablation of atrial fibrillation cerebral vascular accident/transient ischemic attack within 12 months from implant which lead to relevant impairment preexisting unipolar pacemaker</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>